← Leaderboards
Melissa L Bondy
Stanford University
$46,044,245
Attributed
$56,065,915
Total exposure
18
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$65,253,821 · 20
By mechanism
R01$47,959,288 · 8
U54$12,253,788 · 4
P50$2,081,132 · 2
R25$1,881,561 · 1
T32$437,853 · 1
R21$275,688 · 1
Top collaborators
- Maria Eulalia Fernandez8 shared
- Lovell Allan Jones8 shared
- David W Wetter8 shared
- Matthew Neil Bainbridge7 shared
- Benjamin Deneen7 shared
- Luis Guillermo Carvajal Carmona6 shared
- David B Grusky6 shared
- Robert A Hiatt6 shared
Most similar at Stanford University
Same institution · by research overlap
- Jennifer Hah$9,080,295
- Eliza F Chakravarty$3,534,424
- David Matthew Maahs$18,119,674
- Eleni Linos$7,508,257
- David Feldman$8,560,053
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResearch PersonnelBaseGeneticGliomaProgramsResourcesAffectCancer RiskTexasTrainingFundingMemberEpidemiologySamplingTumorFamilyAreaInnovationGenetic PolymorphismInternationalResearch Project GrantsRecruitment ActivitySan Francisco
Grant awards (87)
The Upstream Center: Income Interventions to Address the Fundamental Causes of Cancer$2,026,916
U54 · FY2025 · CA
Administrative Core$337,820
U54 · FY2025 · CA · contact PI
Genetic and Environmental basis of Cancer Risk and Disparities (GECaRD)$271,425
T32 · FY2025 · CA
The Upstream Center: Income Interventions to Address the Fundamental Causes of Cancer$93,130
U54 · FY2025 · CA
The Upstream Center: Income Interventions to Address the Fundamental Causes of Cancer Inequities$1,879,074
U54 · FY2024 · CA
Discovery, Biology and Risk of Inherited Variants in Glioma$730,884
R01 · FY2024 · CA · contact PI
The Upstream Center: Income Interventions to Address the Fundamental Causes of Cancer Inequities$354,274
U54 · FY2024 · CA
Administrative Core$315,782
U54 · FY2024 · CA · contact PI
Genetic and Environmental basis of Cancer Risk and Disparities (GECaRD)$166,428
T32 · FY2024 · CA
The Upstream Center: Income Interventions to Address the Fundamental Causes of Cancer Inequities$61,583
U54 · FY2024 · CA
The Upstream Center: Income Interventions to Address the Fundamental Causes of Cancer Inequities$2,094,963
U54 · FY2023 · CA
Characterizing germline and somatic alterations by glioma subtypes and clinical outcome$923,381
R01 · FY2023 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Glioma$829,381
R01 · FY2023 · CA · contact PI
Administrative Core$443,226
U54 · FY2023 · CA · contact PI
Characterizing germline and somatic alterations by glioma subtypes and clinical outcome$1,498,836
R01 · FY2022 · CA · contact PI
Characterizing germline and somatic alterations by glioma subtypes and clinical outcome$1,529,801
R01 · FY2021 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Glioma$989,011
R01 · FY2021 · CA · contact PI
Cancer Prevention and Population Sciences$39,772
P30 · FY2021 · CA · contact PI
Cancer Prevention and Population Sciences$32,229
P30 · FY2020 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Glioma$793,780
R01 · FY2019 · CA · contact PI
Characterizing germline and somatic alterations by glioma subtypes and clinical outcome$656,870
R01 · FY2019 · CA · contact PI
Characterizing germline and somatic alterations by glioma subtypes and clinical outcome$402,608
R01 · FY2019 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Glioma$168,113
R01 · FY2019 · CA · contact PI
Helping Neuro-oncologists Navigate Expanded Access$155,477
R01 · FY2019 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Glioma$1,043,807
R01 · FY2018 · CA · contact PI
Environmental Health Outcomes Research Among Hurricane Harvey Survivors$275,688
R21 · FY2018 · ES · contact PI
Risk Prediction for ER Negative Breast Cancer Recurrence$593,132
R01 · FY2017 · CA · contact PI
Risk Prediction for ER Negative Breast Cancer Recurrence$614,362
R01 · FY2016 · CA · contact PI
International Case Control Study of Malignant Glioma$1,177,060
R01 · FY2015 · CA · contact PI
Risk Prediction for ER Negative Breast Cancer Recurrence$624,192
R01 · FY2015 · CA · contact PI
Training Program in Pediatric Cancer Epidemiology and Control$346,415
R25 · FY2015 · CA
International Case Control Study of Malignant Glioma$1,836,550
R01 · FY2014 · CA · contact PI
Risk Prediction for ER Negative Breast Cancer Recurrence$603,134
R01 · FY2014 · CA · contact PI
Training Program in Pediatric Cancer Epidemiology and Control$516,699
R25 · FY2014 · CA
Research Project$406,305
U54 · FY2014 · CA · contact PI
International Case Control Study of Malignant Glioma$1,862,222
R01 · FY2013 · CA · contact PI
Risk Prediction for ER Negative Breast Cancer Recurrence$665,785
R01 · FY2013 · CA · contact PI
Training Program in Pediatric Cancer Epidemiology and Control$521,145
R25 · FY2013 · CA
Research Project$234,025
U54 · FY2013 · CA · contact PI
Research Project$64,995
U54 · FY2013 · CA · contact PI
International Case Control Study of Malignant Glioma$3,914,658
R01 · FY2012 · CA · contact PI
Reducing Cancer Disparaties Among Latinos in Texas$786,635
U54 · FY2012 · CA
Research Project$388,906
U54 · FY2012 · CA · contact PI
Training Program in Pediatric Cancer Epidemiology and Control$387,302
R25 · FY2012 · CA
Genetic Modulation of Cognitive Function and outcomes in Glioblastoma Patients$326,603
P50 · FY2012 · CA · contact PI
Reducing Cancer Disparaties Among Latinos in Texas$85,306
U54 · FY2012 · CA
Reducing Cancer Disparaties Among Latinos in Texas$33,333
U54 · FY2012 · CA
International Case Control Study of Malignant Glioma$3,962,501
R01 · FY2011 · CA · contact PI
Reducing Cancer Disparaties Among Latinos in Texas$786,494
U54 · FY2011 · CA
Research Project$464,512
U54 · FY2011 · CA · contact PI
Genetic Modulation of Cognitive Function and outcomes in Glioblastoma Patients$365,069
P50 · FY2011 · CA · contact PI
Training Program in Pediatric Cancer Epidemiology and Control$110,000
R25 · FY2011 · CA
Reducing Cancer Disparaties Among Latinos in Texas$83,510
U54 · FY2011 · CA
Reducing Cancer Disparaties Among Latinos in Texas$58,738
U54 · FY2011 · CA
Reducing Cancer Disparaties Among Latinos in Texas$22,317
U54 · FY2011 · CA
International Case Control Study of Malignant Glioma$3,278,944
R01 · FY2010 · CA · contact PI
Genetic Epidemiology of Glioma International Consortium$2,052,220
R01 · FY2010 · CA · contact PI
Reducing Cancer Disparaties Among Latinos in Texas$821,633
U54 · FY2010 · CA
Research Project$410,311
U54 · FY2010 · CA · contact PI
Genetic Epidemiology of Glioma International Consortium$400,329
R01 · FY2010 · CA · contact PI
Genetic Modulation of Cognitive Function and outcomes in Glioblastoma Patients$326,705
P50 · FY2010 · CA · contact PI
Meningioma: Risk Factors and Quality of Life$232,676
R01 · FY2010 · CA · contact PI
Genetic Epidemiology of Glioma International Consortium$2,253,654
R01 · FY2009 · CA · contact PI
Genetic Modulation of Cognitive Function and outcomes in Glioblastoma Patients$327,684
P50 · FY2009 · CA · contact PI
Molecular and Epidemiologic Classification of early Stage Breast Tumors$304,942
P50 · FY2009 · CA · contact PI
Meningioma: Risk Factors and Quality of Life$232,676
R01 · FY2009 · CA · contact PI
Genetic Epidemiology of Glioma International Consortium$2,259,604
R01 · FY2008 · CA · contact PI
Meningioma: Risk Factors and Quality of Life$232,676
R01 · FY2008 · CA · contact PI
Genetic Modulation of Cognitive Function and outcomes in Glioblastoma Patients$224,839
P50 · FY2008 · CA · contact PI
Molecular and Epidemiologic Classification of early Stage Breast Tumors$205,290
P50 · FY2008 · CA · contact PI
Genetic Epidemiology of Glioma International Consortium$2,314,912
R01 · FY2007 · CA · contact PI
Meningioma: Risk Factors and Quality of Life$232,676
R01 · FY2007 · CA · contact PI
Genetic Epidemiology of Glioma International Consortium$2,614,394
R01 · FY2006 · CA · contact PI
Determinants of Breast Cancer Survival$410,721
R01 · FY2006 · CA · contact PI
Meningioma: Risk Factors and Quality of Life$199,500
R01 · FY2006 · CA · contact PI
Determinants of Breast Cancer Survival$598,685
R01 · FY2005 · CA
Determinants of Breast Cancer Survival$638,634
R01 · FY2004 · CA
MOLECULAR EPIDEMIOLOGY OF GLIOMAS$625,251
R01 · FY2004 · CA
Metabolic Polymorphisms and Survival from Brain Tumors$75,500
R03 · FY2004 · CA
Determinants of Breast Cancer Survival$733,517
R01 · FY2003 · CA
MOLECULAR EPIDEMIOLOGY OF GLIOMAS$609,253
R01 · FY2003 · CA
Metabolic Polymorphisms and Survival from Brain Tumors$75,500
R03 · FY2003 · CA
Determinants of Breast Cancer Survival$681,469
R01 · FY2002 · CA
MOLECULAR EPIDEMIOLOGY OF GLIOMAS$593,727
R01 · FY2002 · CA
MOLECULAR EPIDEMIOLOGY OF GLIOMAS$584,006
R01 · FY2001 · CA
MOLECULAR EPIDEMIOLOGY OF GLIOMAS$604,219
R01 · FY2000 · CA
MOLECULAR AND GENETIC EPIDEMIOLOGY OF GLIOMAS$141,510
P01 · FY2000 · CA